logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
M

Mark J. Levis

Johns Hopkins University

82H指数
600论文数
2.6W被引数
收录论文 111
发表时间
logo
FLT3-ITD MRD is here to stayFLT3-ITD微小残留病（MRD）将成为持续存在的挑战
errBlood Advances
IF7.1
err2026-08-17
err0
errOAAI
errMark J. Levis
err分享
err收藏
QuANTUM-Wild: a Phase III, randomized trial of quizartinib in newly diagnosed FLT3-ITD–negative acute myeloid leukemiaQUANTUM-Wild：一项关于Quizartinib在初诊FLT3-ITD阴性急性髓性白血病中的III期随机临床试验
errFuture Oncology
IF2.6
err2026-07-11
err0
errOAAI
errPau Montesinos; Jessica K. Altman; Lars Bullinger; June-Won Cheong; Amir T. Fathi; Mark J. Levis; Selina Luger; Toshihiro Miyamoto; Esther Natalie Oliva; Alexander E. Perl; Christian Récher; Rebeca Rodriquez Veiga; Jianxiang Wang; Amer M. Zeidan; Li Liu; Yvonne Duong; Jaime E. Connolly Rohrbach; Giorgio Inghirami; Karenza Alexis; Andreas Gosberg; Akash Nahar; Kristy Burns; Naval Daver; Harry P. Erba
err分享
err收藏
ELN-DAVID Recommendations for NGS-based FLT3-ITD MRD Testing in Patients with Acute Myeloid LeukemiaELN-DAVID 关于急性髓系白血病患者基于NGS的FLT3-ITD微小残留病检测的建议
errBlood
IF23.1
err2026-06-05
err0
errOAAI
errChristopher S. Hourigan; Lisanne Beugelink; Jad Othman; Gege Gui; Adam Ivey; Richard Dillon; Christian Thiede; Mark J. Levis; Laura W. Dillon; Andrew H. Wei; Ing Soo Tiong; Sun Loo; Konstanze Döhner; Isabell Arnhardt; Artur Kowalik; Nicola Potter; Dennis Dong Hwan Kim; Claude Preudhomme; Nicolas Duployez; Michael Heuser
err分享
err收藏
A PBD-dimer containing antibody drug conjugate targeting CCRL2 for high-risk MDS/AML including TP53-mutated disease一种靶向CCRL2、含PBD二聚体的抗体药物偶联物，用于治疗高风险MDS/AML（包括TP53突变型疾病）
errBlood Advances
IF7.1
err2026-05-26
err0
errOAAI
errNour Sabiha Naji; Taha Ahmedna; Xinghan Zeng; Brandy Perkins; Zanshe Thompson; Tushar D. Nichakawade; Bum Seok Lee; Evangeline Watson; Theodora Chatzilygeroudi; Li Luo; Bogdan Paun; Melanie Klausner; Teodora Supeanu; Ivana Gojo; Gabriel Ghiaur; Amy E. DeZern; Mark J. Levis; Linda Resar; Richard J. Jones; Styliani Karanika
err分享
err收藏
Quizartinib in newly diagnosed patients with FLT3-ITD–positive AML who received maintenance therapy in QuANTUM-FirstQuizartinib在QuANTUM-First研究中，接受维持治疗的初诊FLT3-ITD阳性AML患者中的应用
errBlood Advances
IF7.1
err2026-04-09
err0
errOAAI
errMark J. Levis; Harry P. Erba; Pau Montesinos; Elżbieta Patkowska; Jorge Cortes; Alexander E. Perl; Hervé Dombret; Sergio Amadori; Jianxiang Wang; Richard F. Schlenk; Li Liu; Yasser Mostafa Kamel; Karima Imadalou; Abderrahmane Laadem; Kristy Burns; Mikkael A. Sekeres
err分享
err收藏
C-C motif chemokine receptor-like 2 promotes the interferon-γ signaling response in myeloid neoplasms with erythroid differentiation and mutated TP53Naji, N.S.; Pasca, S.; Chatzilygeroudi, T.; Toledano-Sanz, P.; Rimando, J.; An, Y.; Hemani, Y.; Perkins, B.; Zeng, X.; Talbot, C.; 等. C-C基序趋化因子受体样2促进具有红系分化和TP53突变髓系肿瘤的干扰素-γ信号反应。Haematologica, 2025. [Google Scholar] [CrossRef]
errHaematologica
IF7.9
err2026-02-01
err3
errOAAI
errNaji, Nour Sabiha; Pasca, Sergiu; Chatzilygeroudi, Theodora; Toledano-Sanz, Pablo; Rimando, Joseph; An, Yuju; Hemani, Yashvi; Perkins, Brandy; Zeng, Xinghan; Talbot Jr, Conover; Paun, Bogdan; Abdulmalik, Abdulmuez; Lossos, Chen; Boronina, Tatianna R.; Sinanidis, Ilias; Tsakiroglou, Panagiotis; Fernandes, Priyanka; Esteb, Christopher; Ambinder, Alexander J.; Cole, Robert N.; Xian, Rena; Gojo, Ivana; Paul, Suman; Levis, Mark J.; Dezern, Amy E.; Luznik, Leo; Karanika, Styliani; Resar, Linda S.; Jones, Richard J.; Bunz, Frederick; Gondek, Lukasz; Arvanitis, Marios; Karantanos, Theodoros
err分享
err收藏
Long-term follow-up of the Baltimore experience with hematopoietic cell transplantation for severe aplastic anemia using post-transplant cyclophosphamide采用移植后环磷酰胺治疗严重再生障碍性贫血的巴尔的摩经验长期随访研究
errTransplantation and Cellular Therapy
IF4.4
err2025-11-05
err0
PREAI
errAmy E. DeZern; Marianna Zahurak; Tyler Cavin; H. Pierse Byrnes; Heather J. Symons; Kenneth R. Cooke; Carol Ann Huff; Tania Jain; Lode J. Swinnen; Philip H. Imus; Nina D. Wagner-Johnston; Richard F. Ambinder; Ivana Gojo; Alexander Ambinder; Mark Levis; Cole Sterling; Javier Bolaños-Meade; Ephraim J. Fuchs; Richard J. Jones; Robert A. Brodsky
err分享
err收藏
Improved outcomes of acute lymphoblastic leukemia after allogeneic blood or marrow transplantation with high-dose post-transplantation cyclophosphamide in the era of more effective pre-transplant therapy
errHAEMATOLOGICA
IF7.9
err2025-11-01
err1
errOAAI
errWebster, Jonathan A.; Reed, Madison; Tsai, Hua-Ling; Imus, Philip H.; Smith, B. Douglas; Ambinder, Alexander J.; Levis, Mark J.; DeZern, Amy E.; Prince, Gabrielle T.; Jain, Tania; Bolanos-Meade, Javier; Gondek, Lukasz P.; Ghiaur, Gabriel; Dalton, William Brian; Karantanos, Theodoros; Paul, Suman; Fuchs, Ephraim J.; Sterling, Cole; Swinnen, Lode J.; Wagner-Johnston, Nina; Ambinder, Richard F.; Gocke, Christian B.; Ali, Syed Abbas; Huff, Carol Ann; Luznik, Leo; Varadhan, Ravi; Jones, Richard J.; Gojo, Ivana
err分享
err收藏
Reply to Gui and Hourigan回复Gui和Hourigan
errBlood Advances
IF7.1
err2025-10-31
err0
errOAAI
errMark J. Levis; Mehdi Hamadani; Yi-Bin Chen
err分享
err收藏
FLT3-ITD measurable residual disease from the QuANTUM-First trialFLT3-ITD可测量残留病灶来自QuANTUM-First试验
errBlood Advances
IF7.1
err2025-10-08
err0
errOAAI
errMark J. Levis; Harry P. Erba; Pau Montesinos; Hee-Je Kim; Radovan Vrhovac; Elżbieta Patkowska; Pavel Žák; Po-Nan Wang; Jaime E. Connolly Rohrbach; Ken C.N. Chang; Li Liu; Yasser Mostafa Kamel; Karima Imadalou; Arnaud Lesegretain; Jorge Cortes; Mikkael A. Sekeres; Hervé Dombret; Sergio Amadori; Jianxiang Wang; Richard F. Schlenk; Alexander E. Perl
err分享
err收藏
Efficacy and safety of blinatumomab for CD19+acute leukemias in patients historically excluded from clinical trials due to comorbiditiesBlinatumomab对由于合并症而被历史性地排除在临床试验之外的CD19+急性白血病患者中的有效性和安全性
errLEUKEMIA RESEARCH
IF2.2
err2025-09-01
err0
errOAAI
errClaiborne, J. Preston; Li, Daniel; Tsai, Hua-Ling; Ghiaur, Gabriel; Smith, B. Douglas; Levis, Mark J.; Dezern, Amy E.; Ambinder, Alex J.; Jain, Tania; Prince, Gabrielle T.; Gondek, Lukasz P.; Karantanos, Theodoros; Dalton, W. Brian; Gojo, Ivana; Webster, Jonathan A.
err分享
err收藏
Impact of transplant conditioning, NPM1 mutations, and measurable residual disease in FLT3-ITD acute myeloid leukemia移植预处理、NPM1突变及FLT3-ITD急性髓系白血病中可测量的微小残留病的影响
errBlood Advances
IF7.1
err2025-07-03
err0
errOAAI
errMark J. Levis; Mehdi Hamadani; Brent R. Logan; Richard J. Jones; Anurag K. Singh; Mark R. Litzow; John R. Wingard; Esperanza B. Papadopoulos; Alexander E. Perl; Robert J. Soiffer; Celalettin Ustun; Masumi Ueda Oshima; Geoffrey L. Uy; Edmund K. Waller; Sumithira Vasu; Melhem Solh; Asmita Mishra; Lori S. Muffly; Hee-Je Kim; Matthias Stelljes; Yuho Najima; Masahiro Onozawa; Kirsty Thomson; Caroline Chen; Nahla Hasabou; Matt Rosales; Jason E. Hill; Stanley C. Gill; Rishita Nuthethi; Denise King; Adam Mendizabal; Steven M. Devine; Mary M. Horowitz; Yi-Bin Chen
err分享
err收藏
The Aza/Ven reshuffleAza/Ven 重组
errBLOOD
IF23.1
err2024-11-21
err0
PREAI
errLevis, M
err分享
err收藏
Azacitidine and Venetoclax Followed By Sequential Gilteritinib Is an Effective Alternative in Very Frail Patients with FLT3-Mutated Acute Myeloid Leukemia阿扎胞苷和维奈克拉序贯吉列替尼是 FLT3 突变急性髓系白血病极脆弱患者的一种有效替代方案。
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errNedumannil, Rithin; Matley, Chelsea; Bajel, Ashish; Levis, Mark J.; Wei, Andrew H.
err分享
err收藏
Quantum-First: Deep-Dive Analysis of FMS-like Tyrosine Kinase 3-Internal Tandem Duplication (FLT3-ITD) Detection Methods Utilized for Enrollment and Longitudinal MRD Detection in Newly Diagnosed (nd) Patients (pts) with FLT3-ITD-Positive (FLT3-ITD+) Acute Myeloid Leukemia (AML)量子优先：对用于新诊断（nd）FLT3-ITD阳性（FLT3-ITD+）急性髓系白血病（AML）患者（pts）入组登记和纵向微小残留病（MRD）检测的FMS样酪氨酸激酶3-内部串联重复（FLT3-ITD）检测方法的深度分析
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errRohrbach, Jaime E. Connolly; Waldron, Edward; Liu, Li; Rivera, Shawn; Subramanya, Sridevi Kayyur; Abraham, Violet; Perl, Alexander E.; Levis, Mark J.
err分享
err收藏
Efficacy and Tolerability of Blinatumomab in Clinical Trial Ineligible Patients with CD19+LeukemiasBlinatumomab在临床试验不符合资格的CD19+白血病患者中的有效性与耐受性
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errClaiborne, John Preston; Li, Daniel; Smith, B. Douglas; Levis, Mark J.; Gojo, Ivana; Dezern, Amy E.; Ambinder, Alexander J.; Jain, Tania; Prince, Gabrielle T.; Gondek, Lukasz P.; Karantanos, Theodoros; Ghiaur, Gabriel; Dalton, William Brian; Webster, Jonathan Allen
err分享
err收藏
Pan-RAS Inhibitor RMC-7977 Overcomes Oncogenic RAS Signaling and Exerts Antileukemic Effects in CMML/AML Cells泛RAS抑制剂RMC-7977克服致癌RAS信号传导，并在CMML/AML细胞中发挥抗白血病作用
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errSeale, Tessa; Perkins, Brandy; Chatzilygeroudi, Theodora; Cole, Soren; Battah, Kareem; Stahl, Maximilian; Levis, Mark J.; Ambinder, Alexander J.; Misale, Sandra; Karantanos, Theodoros
err分享
err收藏
Targeting rapid TKI-induced AXL upregulation overcomes adaptive ERK reactivation and exerts antileukemic effects in FLT3/ITD acute myeloid leukemia
errMOLECULAR ONCOLOGY
IF4.5
err2024-10-12
err0
errOAAI
errSeale, Tessa S.; Li, Li; Bruner, J. Kyle; Chou, Melody; Nguyen, Bao; Seo, Jaesung; Zhu, Ruiqi; Levis, Mark J.; Pratilas, Christine A.; Small, Donald
err分享
err收藏
Health-related quality of life with gilteritinib vs placebo posttransplant for FLT3-ITD+ acute myeloid leukemia
errBLOOD ADVANCES
IF7.1
err2024-09-27
err0
errOAAI
errHamilton, Betty K.; Pandya, Bhavik J.; Ivanescu, Cristina; Elsouda, Dina; Hamadani, Mehdi; Chen, Yi-Bin; Levis, Mark J.; Oshima, Masumi Ueda; Litzow, Mark R.; Soiffer, Robert J.; Ustun, Celalettin; Perl, Alexander E.; Singh, Anurag K.; Geller, Nancy; Hasabou, Nahla; Rosales, Matt; Cella, David; Corredoira, Laura; Pestana, Carolina; Horowitz, Mary M.; Logan, Brent
err分享
err收藏
Complete morphologic response to gilteritinib in ALK-rearranged acute myeloid leukemia
errNPJ PRECISION ONCOLOGY
IF8
err2024-09-10
err0
errOAAI
errAdashek, Jacob J.; Brodsky, Max; Levis, Mark J.
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
H
Hagop M. Kantarjian
H 指数: 230 · 论文数: 5.5K
J
Jörge E. Cortes
H 指数: 179 · 论文数: 3.6K
D
Donna Neuberg
H 指数: 155 · 论文数: 1.7K
G
Guillermo Garcia‐Manero
H 指数: 149 · 论文数: 2.9K
R
Richard A. Larson
H 指数: 147 · 论文数: 1.5K
查看更多